Hospitex Secures Major Public Tender
Hospitex, an Italian leader in medical device production and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), proudly announces its successful bid for a public tender involving the Gaetano Martino University Hospital. This achievement marks a significant milestone in the company’s growth trajectory.
Contract Value and Terms
The awarded contract has a value of €668,000 over three years with an option for two additional years, potentially leading to a total value of €1.025 million. The tender involves supplying alcohol for medical and hospital use, a crucial element for enforcing high standards in healthcare services.
Accreditation and Operational Excellence
Hospitex's recognition as a fiscal warehouse for alcohol by the Italian Customs Agency speaks volumes about its operational capabilities. This esteemed accreditation reflects the company’s ability to thrive within highly regulated environments, demonstrating a commitment to quality and operational excellence.
Expanding Reach Across Europe
This achievement positions Hospitex not just as a local supplier but as an integral player in the European medical health landscape. The company is actively extending its reach to healthcare institutions across Europe, emphasizing its capacity to deliver high-quality medical alcohol solutions efficiently.
CEO Statement
Francesco Trisolini, the CEO of Hospitex, remarked, "Winning this tender solidifies our stronghold in the healthcare sector. Our comprehensive knowledge of regulatory frameworks allows us to meet both domestic and international needs. We are dedicated to supporting the Gaetano Martino University Hospital by supplying essential healthcare products that underline excellence in medical services."
Strategic Positioning of ALIKO SCIENTIFIC
This recent success enhances the strategic positioning of ALIKO SCIENTIFIC in the healthcare and life sciences sectors, furthering its goals for expansion and commitment to innovation in medical technologies.
About ALIKO SCIENTIFIC (Ikonisys SA)
ALIKO SCIENTIFIC, headquartered in Paris, operates as the umbrella company for a network aimed at improving oncology diagnostics. Listed under the ticker ALIKO on Euronext Growth Paris, ALIKO coordinate various industrial and financial activities across its subsidiaries, including Ikonisys Inc. and Hospitex International. The company's mission is to innovate in cancer diagnostics by merging advanced technologies and strategic partnerships to develop a globally recognized center of excellence.
About IKONISYS
Ikonisys is a trailblazer in automated diagnostics, focusing on fluorescence in situ hybridization (FISH) and circulating tumor cell (CTC) detection. Utilizing cutting-edge AI and a fully automated microscopy platform, Ikonisys redefines precision and efficiency in cancer diagnostics, empowering healthcare professionals in delivering customized patient care and enhancing treatment outcomes.
About HOSPITEX
Operating from Florence, Hospitex stands out in cytology innovation, conducting its own R&D to ensure the highest quality standards. As a leader in Liquid-Based Cytology (LBC) technology, Hospitex is uniquely prepared for seamless digital integration, setting the stage for transformative advances in cytology diagnostics.
Frequently Asked Questions
What is the value of the contract secured by Hospitex?
The contract is valued at €668,000 over three years, with an option for extension bringing the total potential value to €1.025 million.
What products will Hospitex supply under this contract?
Hospitex will supply alcohol for medical and hospital use, which is essential for maintaining healthcare service standards.
What distinguishes Hospitex in the healthcare sector?
Hospitex has been recognized as a fiscal warehouse for alcohol by the Italian Customs Agency, highlighting its operational reliability in regulated environments.
Where does Hospitex operate?
While based in Italy, Hospitex serves healthcare facilities throughout Europe, showcasing its capability for broad-scale deliveries of medical alcohol solutions.
How does this tender impact ALIKO SCIENTIFIC?
This success bolsters ALIKO SCIENTIFIC’s strategic position in the healthcare sector, reinforcing its commitment to innovation and growth in medical technologies.
